Steve Pessagno

Executive Director

Steve Pessagno is an employee of GSK, where he has worked in a variety of commercial, operations, and business development roles in his 25 years at the company. Currently an Alliance Director in GSK’s Worldwide Business Development group, Steve manages a portfolio of strategic alliances (primarily in Oncology), oversees the team’s priority projects for Alliance Management operations, and has held leadership roles on several transformative acquisition and divestment deals (examples include GSK’s acquisitions of Reliant Pharmaceuticals, Stiefel Laboratories, Tesaro, and Sierra Oncology; ViiV Healthcare’s acquisition of the HIV business from Bristol Myers Squibb; and the divestment of GSK’s portfolio of marketed Oncology products to Novartis in 2015). Steve holds degrees from the University of Pennsylvania (BA, Communications) and University of Michigan (MBA), and serves on the Board of Directors (Treasurer, Ex-Officio) of the Coalition Against Childhood Cancer (CAC2.org).

Talks About
#businessdevelopment

Preferred Locations
#NorthAmerica